Position in CELU
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$66,477
+$10,996 QoQ
Shares Held
49,983
0.0% QoQ
Ownership
0.173%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in CELU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Valmark Advisers, Inc. holds $452,302 across 2 Biotechnology names. CELU ranks #2 (14.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TARS |
Tarsus Pharmaceuticals, Inc.
|
5,500 | $385,825 | |
| 2 | CELU |
Celularity Inc
This page
|
49,983 | $66,477 |
All Filings in CELU
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $66,477 | 49,983 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $55,481 | 49,983 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $103,464 | 49,983 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $97,966 | 49,983 | Shares | Sole | 2025-07-23 | |
| No filing history on record for this holder in this stock. | ||||||